Hiywot Takkele's Colleagues at QED Therapeutics
Hiywot Takkele's Contact Details
HQ
650-231-4088
650-231-4088
Location
San Francisco,California,United States
San Francisco,California,United States
Company
QED Therapeutics
QED Therapeutics
Hiywot Takkele's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Hiywot Takkele
Hiywot Takkele currently works for QED Therapeutics.
Hiywot Takkele's role at QED Therapeutics is Sr. Director Clinical Operations.
Hiywot Takkele's email address is ***@qedtx.com. To view Hiywot Takkele's full email address, please signup to ConnectPlex.
Hiywot Takkele works in the Research industry.
Hiywot Takkele's colleagues at QED Therapeutics are Sherry Markle, Sudesh Kamath, Mag Sellakumaran, Kathleen Dm, Jack Winnike, Anne Lee, Keith Steward and others.
Hiywot Takkele's phone number is 650-231-4088